DNA Diagnostics Market Report

DNA Diagnostics Market Analysis By Technology (Microarray Based, PCR Based, In-situ Hybridization, NGS DNA Diagnosis), By Application (Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics (HBV, HCV, HIV, TB, CT/NG, HPV, & MRSA), Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, Pharmacogenomics Diagnostic Testing, & Drug Metabolism/P450 Effects), And Segment Forecasts To 2022

  • Published Date: Jan, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-676-9
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 148

Market Segmentation

  • Global DNA Diagnostics/Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

    • Microarrays based diagnostics
    • PCR based diagnostics
    • In-situ hybridization diagnostics
    • NGS DNA diagnosis
  • Global DNA Diagnostics/Testing Application Outlook (Revenue, USD Million, 2012 - 2022)

    • Prenatal DNA Carrier Screening
    • Preimplantation Diagnosis
    • Newborn Genetic Screening
    • Infectious Disease Diagnostics
      • HBV Diagnostic
      • HCV Diagnostic
      • HIV Diagnostic
      • TB Diagnostic
      • CT/NG Diagnostic
      • HPV Diagnostic
      • MRSA Diagnostic
      • Others
    • Oncology Diagnostics & Histopathology
    • Identity Diagnostics & Forensics
    • Pharmacogenomics Diagnostic Testing
    • Drug Metabolism & P450 effects
    • Others
  • Global DNA Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2012 - 2022)
    • North America
      • U.S.
        • U.S. DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • U.S. DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
      • Canada
        • Canada DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • Canada DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
    •  Europe
      • Germany
        • Germany DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • Germany DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
      • UK
        • UK DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • UK DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
    • Asia Pacific
      • Japan
        • Japan DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • Japan DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
      • China
        • China DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • China DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
    • Latin America
      • Brazil
        • Brazil DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • Brazil DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
      • Mexico
        • Mexico DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • Mexico DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others
    •  MEA
      • South Africa
        • South Africa DNA Diagnostics/Testing, by Technology (Revenue, USD Million, 2012 - 2022)
          • Microarrays based diagnostics
          • PCR based diagnostics
          • In-situ hybridization diagnostics
          • NGS DNA diagnosis
        • South Africa DNA Diagnostics/Testing, by Application (Revenue, USD Million, 2012 - 2022)
          • Prenatal DNA Carrier Screening
          • Preimplantation Diagnosis
          • Newborn Genetic Screening
          • Infectious Disease Diagnostics
            • HBV Diagnostic
            • HCV Diagnostic
            • HIV Diagnostic
            • TB Diagnostic
            • CT/NG Diagnostic
            • HPV Diagnostic
            • MRSA Diagnostic
            • Others
          • Oncology Diagnostics & Histopathology
          • Identity Diagnostics & Forensics
          • Pharmacogenomics Diagnostic Testing
          • Drug Metabolism & P450 effects
          • Others

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Application Segments Prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2012 to 2022
  • Revenue estimates for technology up to 2022
  • Regional market size and forecast for technology up to 2022
  • Revenue estimates for application up to 2022
  • Regional market size and forecast for application up to 2022
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.